GOLDMAN SACHS GROUP INC - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 105 filers reported holding ENDOCYTE INC in Q3 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$3,262,000
+45.3%
183,678
+12.9%
0.00%0.0%
Q2 2018$2,245,000
-32.3%
162,672
-55.4%
0.00%0.0%
Q1 2018$3,318,000
+346.0%
365,032
+110.1%
0.00%
Q4 2017$744,000
+4550.0%
173,759
+1443.0%
0.00%
Q3 2017$16,000
-97.5%
11,261
-97.4%
0.00%
Q2 2017$646,000
+580.0%
430,994
+1064.3%
0.00%
Q1 2017$95,000
-55.4%
37,019
-55.6%
0.00%
Q4 2016$213,000
+33.1%
83,440
+61.3%
0.00%
Q3 2016$160,000
-34.2%
51,744
-31.8%
0.00%
Q2 2016$243,000
-39.2%
75,835
-41.2%
0.00%
Q1 2016$400,000
+497.0%
128,943
+674.9%
0.00%
Q4 2015$67,000
+9.8%
16,641
+25.7%
0.00%
Q3 2015$61,000
-55.8%
13,240
-50.1%
0.00%
Q2 2015$138,000
-12.7%
26,553
+5.6%
0.00%
Q1 2015$158,000
+75.6%
25,133
+70.5%
0.00%
Q3 2014$90,000
-92.7%
14,737
-92.1%
0.00%
Q2 2014$1,227,000
-68.8%
186,184
+12.6%
0.00%
-100.0%
Q1 2014$3,938,000
+1239.5%
165,407
+500.6%
0.00%
Q4 2013$294,000
-9.0%
27,539
+13.7%
0.00%
Q3 2013$323,000
+79.4%
24,216
+76.4%
0.00%
Q2 2013$180,000
-46.4%
13,729
-63.4%
0.00%
Q4 2012$336,000
-12.7%
37,524
-2.8%
0.00%
Q3 2012$385,000
+193.9%
38,606
+142.4%
0.00%
Q2 2012$131,000
+21.3%
15,928
-26.7%
0.00%
Q1 2012$108,00021,7330.00%
Other shareholders
ENDOCYTE INC shareholders Q3 2015
NameSharesValueWeighting ↓
Corbenic Partners LLC 32,639$83,0000.09%
Anson Funds Management LP 108,426$276,0000.09%
Leisure Capital Management 30,038$77,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 461,561$1,177,0000.06%
Teza Capital Management LLC 14,542$37,0000.05%
PINNACLE ASSOCIATES LTD 821,543$2,095,0000.04%
Cribstone Capital Management, LLC 28,141$63,0000.04%
Curi RMB Capital, LLC 243,385$621,0000.03%
Acrospire Investment Management LLC 26,061$66,0000.03%
TWO SIGMA SECURITIES, LLC 26,758$68,0000.02%
View complete list of ENDOCYTE INC shareholders